Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Allergan deal-backer Ackman orders board to start talking to Valeant

06.05.2014 / Fierce Pharma

Rumor has it Allergan is scouting about for acquisition targets and white knights to help it dodge an unwanted Valeant Pharmaceuticals takeover. But activist investor Bill Ackman, who has teamed with the Canadian pharma on the pickup bid, doesn't necessarily think that's a good idea.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: